You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • AB0278 Are There Differences in Basal Comorbidities between Rheumatoid Arthritis Patients Treated with Abatacept and Those Treated with Tumor Necrosis Factor Inhibitors?

Article info

Article menu
Download PDFPDF
Abstracts Accepted for Publication
Rheumatoid arthritis - comorbidity and clinical aspects
AB0278 Are There Differences in Basal Comorbidities between Rheumatoid Arthritis Patients Treated with Abatacept and Those Treated with Tumor Necrosis Factor Inhibitors?

Authors

Citation

Hernández M, Sánchez-Piedra C, Inciarte-Mundo J, et al
AB0278 Are There Differences in Basal Comorbidities between Rheumatoid Arthritis Patients Treated with Abatacept and Those Treated with Tumor Necrosis Factor Inhibitors?
Annals of the Rheumatic Diseases 2016;75:994-995.

Publication history

  • First published July 15, 2016.
Online issue publication 
July 15, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions